631914-03-9Relevant academic research and scientific papers
Use of A2B Adenosine Receptor Antagonists for Treating Pulmonary Hypertension
-
, (2012/01/14)
This disclosure relates generally to treating patients having pulmonary hypertension, or symptoms associated therewith, by administering a therapeutically effective amount of an A2B receptor antagonist to the patient.
USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS
-
, (2012/10/18)
Provided are methods of improving the cardiac condition of post-myocardial infarction (MI) patients and reducing cardiovascular death and hospitalization due to heart failure or arrhythmias, by administering a therapeutically effective amount of an A2B adenosine receptor antagonist.
A2B Adenosine receptor antagonists
-
, (2008/06/13)
Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
A2B adenosine receptor antagonists
-
, (2008/06/13)
Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS
-
Page 86, (2010/02/09)
Disclosed are compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
A2B adenosine receptor antagonists
-
Page 41 - 42, (2008/06/13)
Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
